Cutaneous lymphoma

The list below shows The Lymphoma Group's current clinical trials open for recruitment for cutaneous lymphoma patients.

If you would like to know how to access our trials, please see how to contact us.

  • StepPharma/STP938 - Testing STP938 in people with T-cell and B-cell lymphomas that has relapsed or is refractory
  • MOGAT - testing an innovative treatment schedule where mogamulizumab is used before Total Skin Electron Beam Therapy (TSEB) and then as a maintenance treatment in people with cutaneous T-cell lymphoma (CTCL).
  • BioInvent - testing a treatment called BI-1808 with or without Pembrolizumab in people with cutaneous T cell lymphoma. 

With special thanks to the following:

Lymphoma actionCRUKBloodwiseNCRI

For further information on each trial, please visit the Find a trial page on Lymphoma Action’s website.

Last updated: October 2023